Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.

This study compared the pharmacokinetics, pharmacodynamics, and pharmacokinetic/pharmacodynamic (PK/PD) profile of zaleplon, a new pyrazolopyrimidine hypnotic, with those of zolpidem and placebo.
This was a double-blind, 5-period crossover study in which healthy volunteers with no history of sleeping disorder were randomized to 10- or 20-mg oral doses of zaleplon, 10- or 20-mg oral doses of zolpidem, or placebo. The pharmacokinetic characteristics of the active drugs were estimated using a noncompartmental method and NONMEM. Pharmacodynamic characteristics were determined using psychophysical tests, including measures of sedation, mood, mental and motor speed, and recent and remote recall. Results of these tests were used to compare the drugs' relative PK/PD profiles.
Ten healthy male and female volunteers, aged 23 to 31 years, took part in the study. The apparent elimination half-life of zaleplon (60.1+/-8.9 min) was significantly shorter than that of zolpidem (124.5+/-37.9 min) (P < 0.001). Zaleplon produced less sedation than zolpidem at the 2 doses studied (P < 0.001). The sedation scores of the zaleplon groups returned to baseline in less time than those of the zolpidem groups (4 vs 8 hours; P < 0.05). Zaleplon had no effect on recent or remote recall, whereas zolpidem had a significant effect on both measures (P < 0.05).
In this study in 10 young, healthy volunteers, zaleplon was eliminated more rapidly, produced no memory loss, and caused less sedation than zolpidem at the same doses.
AuthorsD Drover, H Lemmens, S Naidu, W Cevallos, M Darwish, D Stanski
JournalClinical therapeutics (Clin Ther) Vol. 22 Issue 12 Pg. 1443-61 (Dec 2000) ISSN: 0149-2918 [Print] United States
PMID11192136 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Acetamides
  • Hypnotics and Sedatives
  • Pyridines
  • Pyrimidines
  • zaleplon
  • zolpidem
  • Acetamides (pharmacokinetics, pharmacology)
  • Adult
  • Cross-Over Studies
  • Double-Blind Method
  • Female
  • Humans
  • Hypnotics and Sedatives (pharmacokinetics, pharmacology)
  • Male
  • Mental Recall (drug effects)
  • Pyridines (pharmacokinetics, pharmacology)
  • Pyrimidines (pharmacokinetics, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: